AG˹ٷ

STOCK TITAN

[144] STERIS plc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

STERIS plc reported a Form 144 notice for an insider sale of ordinary shares. The filing shows 7,900 shares offered through Charles Schwab & Co., with an aggregate market value of $1,909,646.00 and 98,490,606 shares outstanding for the company. The shares were acquired and are to be sold on 08/11/2025 via an employee stock option exercise using a broker payment for a cashless exercise.

The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer. Relationship to the issuer and the identity of the selling person are not specified in the visible fields.

STERIS plc ha presentato un avviso Form 144 relativo alla vendita da parte di un insider di azioni ordinarie. Il deposito indica 7,900 azioni offerte tramite Charles Schwab & Co., con un valore di mercato aggregato di $1,909,646.00 e 98,490,606 azioni in circolazione della società. Le azioni sono state acquisite e saranno vendute il 08/11/2025 mediante un esercizio di opzioni azionarie per dipendenti utilizzando un pagamento al broker per un esercizio senza esborsi in contanti.

Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente. La relazione con l'emittente e l'identità della persona che vende non sono specificate nei campi visibili.

STERIS plc presentó un aviso Form 144 por la venta de acciones ordinarias por parte de un insider. La presentación muestra 7,900 acciones ofrecidas a través de Charles Schwab & Co., con un valor de mercado agregado de $1,909,646.00 y 98,490,606 acciones en circulación de la compañía. Las acciones fueron adquiridas y se venderán el 08/11/2025 mediante un ejercicio de opciones sobre acciones para empleados utilizando un pago al corredor para un ejercicio sin efectivo.

El declarante informa no haber vendido valores en los últimos tres meses e incluye la declaración estándar de que no tiene conocimiento de información material adversa no divulgada sobre el emisor. La relación con el emisor y la identidad de la persona vendedora no se especifican en los campos visibles.

STERIS plc� 내부자에 의한 보통� 매각� 관련하� Form 144 신고서를 제출했습니다. 제출서에� Charles Schwab & Co.� 통해 제시� 7,900�, � 시가총액 $1,909,646.00 � 회사� 발행주식� 98,490,606�가 기재되어 있습니다. 해당 주식은 취득되었으며 08/11/2025종업� 주식옵션 행사� 통해 브로커에 대� 지급을 이용� 무현�(cashless) 방식으로 매각� 예정입니�.

신고인은 지� 3개월 동안 매도� 증권� 없다� 보고했으�, 발행인에 관� 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 진술� 포함하고 있습니다. 발행인과� 관� � 매도인의 신원은 표시� 필드� 명시되어 있지 않습니다.

STERIS plc a déposé un avis Form 144 concernant la vente d'actions ordinaires par un initié. Le dépôt indique 7,900 actions proposées via Charles Schwab & Co., avec une valeur de marché agrégée de $1,909,646.00 et 98,490,606 actions en circulation pour la société. Les actions ont été acquises et seront vendues le 08/11/2025 par le biais d'un exercice d'options d'achat d'actions pour employés utilisant un paiement au courtier pour un exercice sans numéraire.

Le déclarant indique n'avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n'est pas au courant d'informations défavorables importantes non divulguées concernant l'émetteur. La relation avec l'émetteur et l'identité de la personne vendeuse ne sont pas précisées dans les champs visibles.

STERIS plc hat ein Form-144-Meldung für den Verkauf von Stammaktien durch einen Insider eingereicht. Die Einreichung zeigt 7,900 Aktien, angeboten über Charles Schwab & Co., mit einem gesamten Marktwert von $1,909,646.00 und 98,490,606 ausstehenden Aktien des Unternehmens. Die Aktien wurden erworben und sollen am 08/11/2025 durch die Ausübung von Mitarbeiteraktienoptionen verkauft werden, wobei eine Brokerzahlung für eine bargeldlose Ausübung verwendet wird.

Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enthält die standardmäßige Zusicherung, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind. Die Beziehung zum Emittenten und die Identität der verkaufenden Person sind in den sichtbaren Feldern nicht angegeben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale from an employee option exercise; not clearly material to holders.

The Form 144 documents an intended sale of 7,900 ordinary shares of STERIS via Charles Schwab with an aggregate market value of $1,909,646.00, acquired and transacted on 08/11/2025 through a cashless exercise of employee stock options. The filing notes no sales in the prior three months and includes the standard attestation about undisclosed material information. Based on the filing content alone, this is a routine compliance notice documenting an insider sale tied to option exercise rather than a divestiture event; the filing does not provide detail on the seller's role or any broader corporate action.

TL;DR: Compliance-focused disclosure; procedural Form 144 for an employee option exercise sale.

The notice lists the broker (Charles Schwab & Co.), the transaction type (cashless exercise of employee stock options), and key figures: 7,900 shares, aggregate value $1,909,646.00, and issuer outstanding shares 98,490,606. The filing contains the required attestation regarding material adverse information and reports "Nothing to Report" for prior three-month sales. The document does not disclose the filer’s relationship to the issuer or other contextual details that would affect governance interpretation.

STERIS plc ha presentato un avviso Form 144 relativo alla vendita da parte di un insider di azioni ordinarie. Il deposito indica 7,900 azioni offerte tramite Charles Schwab & Co., con un valore di mercato aggregato di $1,909,646.00 e 98,490,606 azioni in circolazione della società. Le azioni sono state acquisite e saranno vendute il 08/11/2025 mediante un esercizio di opzioni azionarie per dipendenti utilizzando un pagamento al broker per un esercizio senza esborsi in contanti.

Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente. La relazione con l'emittente e l'identità della persona che vende non sono specificate nei campi visibili.

STERIS plc presentó un aviso Form 144 por la venta de acciones ordinarias por parte de un insider. La presentación muestra 7,900 acciones ofrecidas a través de Charles Schwab & Co., con un valor de mercado agregado de $1,909,646.00 y 98,490,606 acciones en circulación de la compañía. Las acciones fueron adquiridas y se venderán el 08/11/2025 mediante un ejercicio de opciones sobre acciones para empleados utilizando un pago al corredor para un ejercicio sin efectivo.

El declarante informa no haber vendido valores en los últimos tres meses e incluye la declaración estándar de que no tiene conocimiento de información material adversa no divulgada sobre el emisor. La relación con el emisor y la identidad de la persona vendedora no se especifican en los campos visibles.

STERIS plc� 내부자에 의한 보통� 매각� 관련하� Form 144 신고서를 제출했습니다. 제출서에� Charles Schwab & Co.� 통해 제시� 7,900�, � 시가총액 $1,909,646.00 � 회사� 발행주식� 98,490,606�가 기재되어 있습니다. 해당 주식은 취득되었으며 08/11/2025종업� 주식옵션 행사� 통해 브로커에 대� 지급을 이용� 무현�(cashless) 방식으로 매각� 예정입니�.

신고인은 지� 3개월 동안 매도� 증권� 없다� 보고했으�, 발행인에 관� 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 진술� 포함하고 있습니다. 발행인과� 관� � 매도인의 신원은 표시� 필드� 명시되어 있지 않습니다.

STERIS plc a déposé un avis Form 144 concernant la vente d'actions ordinaires par un initié. Le dépôt indique 7,900 actions proposées via Charles Schwab & Co., avec une valeur de marché agrégée de $1,909,646.00 et 98,490,606 actions en circulation pour la société. Les actions ont été acquises et seront vendues le 08/11/2025 par le biais d'un exercice d'options d'achat d'actions pour employés utilisant un paiement au courtier pour un exercice sans numéraire.

Le déclarant indique n'avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n'est pas au courant d'informations défavorables importantes non divulguées concernant l'émetteur. La relation avec l'émetteur et l'identité de la personne vendeuse ne sont pas précisées dans les champs visibles.

STERIS plc hat ein Form-144-Meldung für den Verkauf von Stammaktien durch einen Insider eingereicht. Die Einreichung zeigt 7,900 Aktien, angeboten über Charles Schwab & Co., mit einem gesamten Marktwert von $1,909,646.00 und 98,490,606 ausstehenden Aktien des Unternehmens. Die Aktien wurden erworben und sollen am 08/11/2025 durch die Ausübung von Mitarbeiteraktienoptionen verkauft werden, wobei eine Brokerzahlung für eine bargeldlose Ausübung verwendet wird.

Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enthält die standardmäßige Zusicherung, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind. Die Beziehung zum Emittenten und die Identität der verkaufenden Person sind in den sichtbaren Feldern nicht angegeben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for STERIS (STE) report?

The filing reports an intended sale of 7,900 ordinary shares of STERIS with an aggregate market value of $1,909,646.00 via Charles Schwab.

When were the shares acquired and when is the sale dated in the Form 144?

The shares were acquired on 08/11/2025 by an employee stock option exercise and the approximate date of sale is listed as 08/11/2025.

How were the shares paid for in the acquisition according to the filing?

The filing states the acquisition/payment method as a Broker Payment for Cashless Exercise following an employee stock option exercise.

Does the filing report any securities sold by the person in the prior three months?

No. The Form 144 section for securities sold during the past three months states "Nothing to Report".

Which broker is handling the proposed sale?

The broker named in the filing is Charles Schwab & Co., Inc. located at the address shown in the notice.

Does the Form 144 disclose the filer’s relationship to STERIS?

The visible filing fields do not specify the filer’s relationship to the issuer; that information is not provided in the displayed content.
Steris Plc

NYSE:STE

STE Rankings

STE Latest News

STE Latest SEC Filings

STE Stock Data

23.92B
98.18M
0.3%
95.58%
0.86%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
DUBLIN